Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS North America Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Preview AMS TV
Features
AMS Features
News & Publications
AMS Bookstore
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Emerging novel therapeutic agents for the treatment of patients with prurigo nodularis
By
- AMS
posted
Jan 04, 2020 04:59 AM
0
Recommend
Volume 32, Issue 7
, November 2021, Page 741-744
.
0 comments
1 view
Permalink
Related Content
Comparing the effects of proactive treatment with tacrolimus ointment and mometasone furoate on the epidermal barrier structure and ceramide levels of patients with atopic dermatitis
- AMS
Added Jan 04, 2020
Blog Entry
The therapeutic effects of blocking IGF-R1 on mice model of skin cancer
- AMS
Added Jan 04, 2020
Blog Entry
A split-face randomized controlled trial of treatment with broadband light for enlarged facial pores
- AMS
Added Dec 05, 2019
Blog Entry
Randomized, controlled trial testing the effectiveness and safety of 2.5% and 5% benzoyl peroxide for the treatment of pitted keratolysis
- AMS
Added Jan 04, 2020
Blog Entry
Efficacy and safety of artemether emulsion for the treatment of mild-to-moderate acne vulgaris: a randomized pilot study
- AMS
Added Jan 09, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic